| 16.42 Data as of May 17 |  -0.07 / -0.42%Today’s Change | 14.53 Today|||52-Week Range 23.54 | -2.20% Year-to-Date |
| Previous close | 16.49 |
| Today’s open | 16.60 |
| Day’s range | 16.38 - 16.64 |
| Volume | 214,666 |
| Average volume (3 months) | 160,868 |
| Market cap | $762.2M |
| Dividend yield | -- |
| Earnings growth (last year) | +32.50% |
| Earnings growth (this year) | -- |
| Earnings growth (next 5 years) | +20.00% |
| Revenue growth (last year) | +6.25% |
| P/E ratio | -- |
| Price/Sales | 2.35 |
| Price/Book | 1.57 |
| Today’s change | Today’s % change | |
|---|---|---|
| LMNXLuminex Corp | +0.30 | +1.66% |
| EXASExact Sciences Corp | -0.26 | -2.40% |
| OMCLOmnicell Inc | +0.15 | +0.80% |
| ABMDAbiomed Inc | +0.21 | +0.93% |
| Next reporting date | August 13, 2013 |
| EPS forecast (this quarter) | -$0.09 |
| Annual revenue (last year) | $277.5M |
| Annual profit (last year) | -$21.7M |
| Net profit margin | -7.84% |
Sector Health Technology |
Industry Medical Specialties |
President & Chief Executive Officer David H. Mowry |
Chief Financial Officer Shawn T. McCormick, MBA, CPA |
Corporate headquarters Amsterdam, Noord-holland |
.
